These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16309891)

  • 1. Significance of serum CXCL10/IP-10 level in type 1 diabetes.
    Shigihara T; Oikawa Y; Kanazawa Y; Okubo Y; Narumi S; Saruta T; Shimada A
    J Autoimmun; 2006 Feb; 26(1):66-71. PubMed ID: 16309891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
    Antonelli A; Fallahi P; Ferrari SM; Pupilli C; d'Annunzio G; Lorini R; Vanelli M; Ferrannini E
    Diabet Med; 2008 Nov; 25(11):1349-53. PubMed ID: 19046227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.
    Narumi S; Kaburaki T; Yoneyama H; Iwamura H; Kobayashi Y; Matsushima K
    Eur J Immunol; 2002 Jun; 32(6):1784-91. PubMed ID: 12115662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I; Jalkanen S; Hänninen A
    Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of monocyte chemoattractant protein-1 in the pancreas of mice.
    Li D; Zhu SW; Liu DJ; Liu GL; Shan ZY
    Chin Med J (Engl); 2005 Aug; 118(15):1269-73. PubMed ID: 16117880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.
    Seifarth C; Mack M; Steinlicht S; Hahn EG; Lohmann T
    Horm Metab Res; 2006 Mar; 38(3):167-71. PubMed ID: 16673207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
    Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
    Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IP-10 and type 1 diabetes: a question of time and location.
    Christen U; Von Herrath MG
    Autoimmunity; 2004 Aug; 37(5):273-82. PubMed ID: 15672495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine.
    Marro ML; Daniels DA; McNamee A; Andrew DP; Chapman TD; Jiang MS; Wu Z; Smith JL; Patel KK; Gearing KL
    Biochemistry; 2005 Jun; 44(23):8449-60. PubMed ID: 15938634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.
    Yamada S; Oikawa Y; Sakai G; Atsumi Y; Maruyama T; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():186-9. PubMed ID: 17130553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.
    Morimoto J; Yoneyama H; Shimada A; Shigihara T; Yamada S; Oikawa Y; Matsushima K; Saruta T; Narumi S
    J Immunol; 2004 Dec; 173(11):7017-24. PubMed ID: 15557199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterovirus markers and serum CXCL10 in children with type 1 diabetes.
    Berg AK; Tuvemo T; Frisk G
    J Med Virol; 2010 Sep; 82(9):1594-9. PubMed ID: 20648615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IP-10 and type 1 diabetes: a question of time and location.
    Christen U; von Herrath MG
    Autoimmunity; 2004 Jun; 37(4):273-82. PubMed ID: 15518041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.